TMAO manifests opposite effects given that it can directly activate platelets, augmenting the likelihood of thrombosis and stroke as well as increasing the expression of pro-inflammatory cytokines, such as TNF-α, IL-6, and C reactive protein [82]. The gene discussed is TNF; the disease is deep vein thrombosis.